These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 16936125)

  • 1. Plasma homocysteine and cysteine levels in retinal vein occlusion.
    Pinna A; Carru C; Zinellu A; Dore S; Deiana L; Carta F
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4067-71. PubMed ID: 16936125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased plasma cysteinylglycine and taurine levels in branch retinal vein occlusion.
    Pinna A; Zinellu A; Franconi F; Solinas G; Carru C
    Ophthalmic Res; 2010; 43(1):26-32. PubMed ID: 19829009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma thiols and taurine levels in central retinal vein occlusion.
    Pinna A; Zinellu A; Franconi F; Carru C
    Curr Eye Res; 2010 Jul; 35(7):644-50. PubMed ID: 20597650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-6-phosphate dehydrogenase deficiency in retinal vein occlusion.
    Pinna A; Carru C; Solinas G; Zinellu A; Carta F
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2747-52. PubMed ID: 17525208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion.
    Di Crecchio L; Parodi MB; Sanguinetti G; Iacono P; Ravalico G
    Ophthalmology; 2004 May; 111(5):940-5. PubMed ID: 15121372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia and low methionine stress are risk factors for central retinal venous occlusion in an Indian population.
    Narayanasamy A; Subramaniam B; Karunakaran C; Ranganathan P; Sivaramakrishnan R; Sharma T; Badrinath VS; Roy J
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1441-6. PubMed ID: 17389469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retinal vein occlusion and hyperhomocysteinemia].
    Blondel J; Glacet-Bernard A; Bayani N; Blacher J; Lelong F; Nordmann JP; Coscas G; Soubrane G
    J Fr Ophtalmol; 2003 Mar; 26(3):249-53. PubMed ID: 12746600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocysteinemia in central retinal vein occlusion in young adults.
    Parodi MB; Di Crecchio L
    Semin Ophthalmol; 2003 Sep; 18(3):154-9. PubMed ID: 15513477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematologic abnormalities associated with various types of retinal vein occlusion.
    Hayreh SS; Zimmerman MB; Podhajsky P
    Graefes Arch Clin Exp Ophthalmol; 2002 Mar; 240(3):180-96. PubMed ID: 11935275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma total homocysteine and retinal vascular disease.
    Martin SC; Rauz S; Marr JE; Martin N; Jones AF; Dodson PM
    Eye (Lond); 2000 Aug; 14 ( Pt 4)():590-3. PubMed ID: 11040905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia: a new risk factor for central retinal vein occlusion.
    Vine AK
    Trans Am Ophthalmol Soc; 2000; 98():493-503. PubMed ID: 11190038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of homocysteine concentrations in patients with retinal vein occlusion versus thrombotic and atherosclerotic disorders.
    Kesler A; Shalev V; Rogowski O; Shimron O; Shainberg B; Sela BA; Shapira I; Salomon O; Berliner S
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):259-62. PubMed ID: 18469545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine and retinal vein occlusion: a population-based study.
    Chua B; Kifley A; Wong TY; Mitchell P
    Am J Ophthalmol; 2005 Jan; 139(1):181-2. PubMed ID: 15652845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma homocysteine levels and vitamin B status in patients with Pseudoexfoliation syndrome.
    Saricaoglu MS; Karakurt A; Sengun A; Hasiripi H
    Saudi Med J; 2006 Jun; 27(6):833-7. PubMed ID: 16758045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effect of antiplatelet therapy in retinal vein occlusion evaluated by the particle-counting method using light scattering.
    Yamamoto T; Kamei M; Yokoi N; Yasuhara T; Tei M; Kinoshita S
    Am J Ophthalmol; 2004 Nov; 138(5):809-17. PubMed ID: 15531317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinemia: a risk factor for retinal vein occlusion.
    Yildirim C; Yaylali V; Tatlipinar S; Kaptanoğlu B; Akpinar S
    Ophthalmologica; 2004; 218(2):102-6. PubMed ID: 15004498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma asymmetric dimethylarginine (ADMA) levels in retinal venous occlusive disease.
    Zinellu A; Pinna A; Sotgia S; Zinellu E; Usai MF; Carta F; Gaspa L; Deiana L; Carru C
    Clin Chem Lab Med; 2008; 46(3):387-92. PubMed ID: 18254706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in plasma TxB2 and 6-keto-PGF1 alpha in patients with retinal vein occlusion].
    Wu YZ
    Zhonghua Yan Ke Za Zhi; 1993 Nov; 29(6):359-61. PubMed ID: 8020381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticardiolipin IgG antibody and homocysteine as possible risk factors for retinal vascular occlusive disease in thai patients.
    Atchaneeyasakul LO; Trinavarat A; Bumrungsuk P; Wongsawad W
    Jpn J Ophthalmol; 2005; 49(3):211-5. PubMed ID: 15944825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hyperhomocystinemia in retinal vascular occlusive disease.
    Sottilotta G; Oriana V; Latella C; Luise F; Piromalli A; Ramirez F; Mammi C; Occhiuto A; Lombardo VT
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):104-7. PubMed ID: 17164500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.